VIRUSES vs. SUPERBUGS
The book and the author Book reviews Blog
 and news Commented links
  1. •Phage therapy literature
Any
questions? Buy
the book Book excerpt What is it 
all about? Home
 
  1. Phage therapy literature
  2.  
  3. Phage therapy has a rich history. The first paper that has to do with it was published in 1896.
  4. On this page you can find the literature of the field I was able to track down. The list will be updated when new references come in. Last update: November 2007
  5. I appreciate hints for references I missed: thaeusler at vtxmail.ch
  1. •Abdul-Hassan, H.S. et al. (1990) ‘Bacteriophage therapy of pseudomonas burn wound sepsis‘ Ann Mediterr Burn Club 4:262-264
  2. •Ackermann, H.-W. (2001) ‘The rise of bacteriophages‘ Virol 5:35-43
  3. •Adamia, R. et al: (1990) ‘The virulent bacteriophage IRA of Salmonella typhimurium: cloning of phage genes that are potentially lethal for the host cell‘ J Basic Microbiol 30:707-716
  4. •Adhya, S. et al. (2005) ‘2004 ASM Conference on the New Phage Biology: the 'Phage Summit'‘ Mol Microbiol 55:1300-14
  5. •Ahmad, S. I. (2002) ‘Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics‘ Med Hypotheses 58:327-31
  6. •Akimkin, V.G. et al. (1998) ‘Ispol'zovanie adaptirovannogo sal'monelleznogo bakteriofaga v praktike lecheniia i profilaktiki nozokomial'nogo sal'monelleza‘ [‘Practical use of adapted Salmonella bacteriophage for the treatment and prevention of nosocomial infections‘]. Zhurn Mikrobiol Epidem Immunobiol 85-86
  7. •Alisky, J. et al. (1998) ‘Bacteriophages show promise as antimicrobial agents‘ J Infect 36:5-15
  8. •Anonymus (1930) ‘Bacteriophage therapy‘ Ind Med Gaz 65:91
  9. •Anonymus (1931) ‘Limitations of Bacteriophage Therapy‘ JAMA 96: 693
  10. •Anonymus (1932) ‘Further limitations of Bacteriophage Therapy‘ JAMA 98:1190
  11. •Anonymus (1933) Editorial 100:1431-1432
  12. •Anonymus (1933) Editorial JAMA 100:1603-1604
  13. •Anonymus (2006) [‘Ambivalent bacteriophages of different species active on Escherichia coli K12 and Salmonella sps. strains‘] Genetika 42:159-68
  14. •Asheshov, I. (1922) Compt Rend Soc Biol 87:168
  15. •Asheshov, I. et. al. (1931) ‘The treatment of cholera with bacteriaphage‘ Ind med Gaz 66:179
  16. •Asheshov, I. et. al. (1937) Lancet 1:319-320
  17. •Atterbury, R. J. et al. (2007) ‘Bacteriophage therapy to reduce salmonella colonization of broiler chickens‘ Appl Environ Microbiol 73:4543-9
  18. •Babsky, E. B. et al. (eds) Microbiology and Epidemiology – Achievements of Soviet Medicine in the Patriotic War, Medical Publications (English edition)
  19. •Barrow, P.A. and Soothill, J.S. (1997) ‘Bacteriophage Therapy and Prophylaxis: rediscovery and renewed assessment of the potential‘ Trends Microbiol 5:268-271
  20. •Barrow, P.A. et al. (1998) ‘Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves‘ Clin Diag Lab Immunol 5:294-298
  21. •Beckerich, A., Hauduroy, P. (1922) ‘Le bactériophage dans le traitment de la fièvre typhoïde‘ Compt Rend Soc Biol 86:168
  22. •Belikov, P.E. (1947) ‘The fight against intestinal infections‘ Am Rev Sov Med 4:238-42
  23. •Berchieri, A. et al. (1991) ‘The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium‘ Res Microbiol 142:541-549
  24. •Bertoye et. al. (1959) ‘Les bacteriophages adaptes dans le traitement des infections a germes resistant aux antibiotiques‘ J Med Lyon 20. Mai:465-471
  25. •Bertschinger, J.P. (1957) ‘Le bactériophage’ Schw Apothekenzeit 95:479–87
  26. •Biswas, B. et al. (2002) ‘Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium‘ Infect Immun 70:204-10
  27. •Blahova, J. et al. (2001) ‘Bacteriophages transducing antibiotic resistance from a cluster of lysogenic strains of Pseudomonas aeruginosa isolated from patients‘ J Chemother 13:331-333
  28. •Bock, E (1939) ‘Zur Anwendung von Bakteriophagen in der Therapie bei der Wehrmacht‘ Dtsch Mil-Arzt 4:273
  29. •Bogovazova, G.G. et al. (1991) [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection]. [Russian]. Zhurn Mikrobiol, Epidem i Immunobiol 4:5-8
  30. •Bogovazova, G.G. et. al. (1992). [Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages]. [Russian]. Zhurn Mikrobiol, Epidem i Immunobiol 30-33.
  31. •Boratinski, J. et al. (2004) ‘Preparation of endotoxin-free bacteriophages‘ Cell Mol Biol Lett 9:253-9
  32. •Bordet, J. et Ciuca, M. (1920) ‘Excsudats leucocytaires et autolyses microbiennes transmissible‘ Compt Rend Soc Biol 83:1296
  33. •Bordet, J. et Ciuca, M. (1920) ‘Le bacteriophage de d’Herelle, sa production et son interpretation‘ Compt rend Soc Biol 83:1296
  34. •Bordet, J. et Ciuca, M. (1921) ‘Autolyse microbienne et serum antilytique‘ Compt Rend Soc Biol 84:280
  35. •Bordet, J. et Ciuca, M. (1921) ‘Determinisme de l’autolyse microbienne transmissible‘ Compt Rend Soc Biol 84:276
  36. •Bordet, J. et Ciuca, M. (1921) ‘Evolution des cultures de coli lysogene‘ Compt Rend Soc Biol 84:747
  37. •Bordet, J. et Ciuca, M. (1921) ‘Guerison et retour a l’etat primitif, par le serum antilytique, du coli lysogene‘ Compt Rend Soc Biol 84:748
  38. •Bordet, J. et Ciuca, M. (1921) ‘Remarques sur l’histoire des recherches, concernant la lyse microbienne transmissible‘ Compt Rend Soc Biol 84:745
  39. •Bordet, J. et Ciuca, M. (1921) ‘Spécificité de l’autolyse microbienne transmissible‘ Compt Rend Soc Biol 84:278
  40. •Bordet, J. (1921) ‘Discussion on the bacteriophage‘ BMJ, 2:289-297
  41. •Bordet, J. (1924) ‘La théorie de l’autolyse transmissible et les objections de d‘Herelle‘ Compt Rend Soc Biol 90:96-8
  42. •Bordet, J. (1925) ‘La théorie de l’autolyse transmissible et les objections de d‘Herelle‘ Compt Rend Soc Biol 93:1432
  43. •Bordet, J. (1925) ‘Pouvoir lysogene actif ou spontane et pouvoir lysogene passif ou provoqué‘ Compt rend Soc Biol 93:1054
  44. •Bordet, J. (1926) ‘A propos de la note ci-dessus de d‘Herelle‘ Compt Rend Soc Biol 94:975
  45. •Bordet, J. (1931) ‘Croonian Lecture-The theories of bacteriophage‘ Proc Roy Soc London Ser B 107:398-417
  46. •Bower, AG (1938) ‘Modern treatment of typhoid fever‘ Mil Surgeon 83:70
  47. •Boyd, J.S.K. and Portnoy, B. (1944) ‘Bacteriophage therapy in bacillary dysentery‘ Trans Roy Soc Trop Med Hyg 37:243-262
  48. •Bronfenbrenner, J.J. and Sulkin, E. (1939) ‘Bacteriophage therapy. II. Prophylactic and therapeutic effect of bacteriophage and of antivirus in experimental infections of the eye‘ J Infect Dis 65:58
  49. •Bronfenbrenner, J.J. and Sulkin, E. (1939) ‘Bacteriophage therapy. III. On the nature of the deleterious effect of the local application of staphylococcus bacteriophage‘ J Infect Dis 65:64-72
  50. •Broxmeyer, L. et al. (2002) ‘Killing of Mycobacterium avium and Mycobacterium tuberculosis by a Mycobacteriophage Delivered by a Nonvirulent Mycobacterium: A Model for Phage Therapy of Intracellular Bacterial Pathogens‘J Infect Dis 186:1155-60
  51. •Brüssow, H. (2005) ‘Phage therapy: the Escherichia coli experience‘ Microbiol 151:2133-40
  52. •Bruttin, A. and Brüssow, H. (2005) ‘Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy‘ Antimicrob Agents Chemother 49:2874-8
  53. •Bruynoghe, R. and J. Maisin (1921) ‘Essais de therapeutique au moyen du bacteriophage du staphylocoque‘ C R Soc Biol 85:1120-1121
  54. •Bruynoghe, R. and Maisin, J. (1921) ‘Essais de therapeutique au moyen du bacteriophage du staphylocoque‘ C R Soc Biol 85:1118
  55. •Bruynoghe, R. and Maisin, J. (1921) ‘Essais de therapeutique au moyen du bacteriophage du staphylocoque‘ C R Soc Biol 85:1122
  56. •Bryant, R.E. et al. (1965) ‘Treatment of recurrent furunculosis with staphylococcal bacteriophage-lysed vaccine‘ JAMA 194:11-14
  57. •Bull, J.J. et al. (2002) ‘Dynamics of success and failure in phage and antibiotic therapy in experimental infections‘ BMC Microbiol 2:35
  58. •Burckhardt (1944) ‘Placentadurchlässigkeit für Phagen‘ Ph.D. Thesis Univ. of Basel
  59. •Burnet, F. and McKie, M. (1929) ‘Observations on a permanently lysogenic strain of B. enteridis gaerther‘ Austral J Exptl Biol Med Sci 6:277-284
  60. •Burnet, F.M. (1930) ‘Bacteriophage and cognate phenomena‘ in A System of bacteriology, Vol. 7, London, pp. 463-509
  61. •Burnet, F.M. et al. (1930) ‘Investigations on bacilliary dysentery in infants, with special reference to the bacteriophage phenomena‘ Med J Austral 2:71-78
  62. •Burnet, F.M. (1934). ‘The bacteriophages‘ Biol Rev Cambridge Phil Soc 9:332-350
  63. •Caldwell, J. (1928) ‘Bacteriologic and bacteriophagic study of infected urines‘ J Infect Dis 39:343-362
  64. •Cao, J. et al. (2000) ‘Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth‘  Biochim Biophys Acta 1474:107-113
  65. •Capparelli, R. et al. (2007) ‘Experimental Phage Therapy against Staphylococcus aureus in Mice.‘ Antimicrob Agents Chemother 2007 518:2765-73
  66. •Carlton, R.M. (1999) ‘Phage therapy: past history and future prospects‘ Arch Immunol Ther Exp 47:267-274
  67. •Carrera, M.R. et al. (2004) ‘Treating cocaine addiction with viruses‘ PNAS 101:10416-10421
  68. •Cerveny, K.E. et al. (2002) ‘Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice‘ Infect Immun 70:6251-62
  69. •Chang, H.-C. et al. (2005) ‘Isolation and Characterization of Novel Giant Stenotrophomonas maltophilia Phage {phi}SMA5‘ Appl Environ Microbiol 71:1387-93
  70. •Chanishvili, N. et al. (2001) ‘Phages and their application against drug resistant bacteria’ J Chem Technol Biotechnol 76:1–11
  71. •Cheng, Q. et al. (2005) ‘Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage, lytic enzyme‘ Antimicrob Agent Chemother 49:111-117
  72. •Cherwonogrodzky, J.W. (2005) ‘Research strategies for the treatment of biothreats‘ Curr Opin Pharmacol 5:465-72
  73. •Chibani-Chennoufi, S. et al. (2004) ‘Isolation of Escherichia coli bacteriophages from the stool of paediatric diarrhoea patients in Bangladesh’, J Bact 186:8287–94
  74. •Chibani-Chennoufi, S. et al. (2004) ‘In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli phages: Implications for Phage Therapy‘ Antimicrob Agents Chemother 48:2558-69
  75. •Choudhury and Morison, J. (1929) ‘The spread of dysentery in a khasi village and its treatment with bacteriophage‘ Ind Med Gaz 64
  76. •Cislo, M. et al. (1987) ‘Bacteriophage treatment of suppurative skin infections‘ Arch Immunolog Therap Exp (Warsz) 35:175-183
  77. •Ciuca, M. (1923) ‘Présence de principe lytique pour le bacille de Shiga et le colibacille dans les selles des choleriques‘ Compt Rend Soc Biol 88:143
  78. •Clajus, W. (1959) ‘Die therapeutische Anwendung von Bakteriophagen unter besonderer Berücksichtigung des Typhus and Paratypus‘ Zentralbl Bakteriol Parasitenkd Infektionskr Hyg Abt 1 Ref 170:427-495
  79. •Clark, P.F. and Schiedt, C.A. (1927) ‘A bacteriophage active against a virulent hemolytic streptococcus‘ Proc Soc Exp Biol 24: 635-639
  80. •Clauberg, K.W. (1944) ‘Therapeutische und prophylaktische Massnahmen bei Typhus- Paratyphus- und Diphterie-Bazillenausscheidern‘ Thp Gegenw 85:58
  81. •Coleman, D.C. et al. (1989) ‘Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: Molecular mechanism of triple conversion‘ J Gen Micr 135: 1679-1697
  82. •Compton, A. (1942) ‘Phage therapy in diarrhoea and dysentery‘ BMJ I:719-720
  83. •Compton, A. (1944) ‘Results of bacteriophage treatment of bacillary dysentery at Alexandria A statistical retrospect‘ Lancet v2:192-193
  84. •Compton, A. (1949) ‘Felix d’Herelle (Obituary)‘ Nature 163:984-985
  85. •Corbel, M.J. and Morris, J.A. (1980) ‘Investigation of the effect of Brucella-phage on the course of experimental infection with Brucella abortus‘ Brit Vet J 136:278-289
  86. •Couvy, L. und Popoff (1931) ‘Essai de traitement de la peste par le bacteriophage‘ Presse med 36:817
  87. •D‘Herelle, F. (1916) ‘Sur un bacille dysenterique atypique‘ Ann Inst Pasteur 30:145-7
  88. •D‘Herelle, F. (1917). ‘Sur un microbe invisible antagoniste des bacteries dysentèriques‘ Compt Rend Acad Sci Paris 165:373
  89. •D‘Herelle (1920) ‘Sur le microbe Bacteriophage. Compt rend Soc Biol 83:247
  90. •D’Herelle, F. (1920) ‘Phénomènes coincidant avec l’aquisition de la resistance des bacteries a l’action du bacteriophage‘ Compt Rend Soc Biol 83:384
  91. •D’Herelle, F. (1920) ‘Sur la résistance des bacteries à l’action du microbe  Bacteriophage‘ Compt rend Soc Biol. 83:97
  92. •D’Herelle, F. (1920) ‘Sur le microbe bacteriophage‘ Compt rend Soc Biol 83:1318
  93. •D’Herelle, F. (1920) Sur la nature du  Bacteriophage‘ Compt rend Soc Biol 83:339
  94. •D’Herelle, F. and Eliava, G. (1921) ‘Sur le serum anti-bacteriophage‘ Compt Rend Soc Biol 84:719
  95. •D’Herelle, F. (1921) ‘Le microbe bactériophage, agent d'immunité dans la peste et la barbone‘ C R Acad Sci Ser D 172:99
  96. •D’Herelle, F. (1921) Le bactériophage: son rôle dans l'immunité, Masson
  97. •D‘Herelle, F. (1921) ‘Le bactériophage: Son rôle dans l'immunité‘ Presse méd 29:463
  98. •D‘Herelle, F. (1922) The Bacteriophage: Its Role in Immunity Williams and Wickens Co./Waverly Press
  99. •D‘Herelle, F. et al. (1922) ‘Discussion on the Bacteriophage (Bacteriolysin) from the Ninetieth Annual Meeting of the British Medical Association, Glasgow, July, 1922‘ BMJ 2:289-297
  100. •D’Herelle, F. (1923) ‘Sur l’autonomie du bacteriophage‘ Compt Rend Soc Biol 87:25
  101. •D’Herelle, F. (1923) ‘Sur l’etat physique du bacteriophage‘ Compt Rend Soc Biol 87:27
  102. •D’Herelle, F. (1923) Les défenses de l'organisme, Ernest Flammarion
  103. •D‘Herelle (1923) ‘Sur la presence du bacteriophage dans les leucocytes‘ Compt. Rend. Soc. Biol. 87:477
  104. •D’Herelle, F. (1924) Immunity in natural infections and disease, Smith D’Herelle, F. (1925) ‘Essai de traitement de la peste bubonique par le bacteriophage‘ Presse med 33:1393-94
  105. •D’Herelle, F. (1926) ‘Sur la theorie de l’autolyse transmissible de Bordet et Ciuca‘ Compt rend Soc Biol 94:973
  106. •D’Herelle, F. (1926) Le Bactériophage et son comportement, Masson et Cie
  107. •D’Herelle, F. (1928) Le Choléra asiatique, Masson
  108. •D’Herelle, F et. al (1929) ‘Studies on asiatic cholera‘ Ind Med Res Mem 14:1-161
  109. •D’Herelle, F. (1930) The bacteriophage and its behaviour, Ballier, Tindall & Cox, London/The Williams and Wilkins Company, Baltimore
  110. •D’Herelle, F. and Smith G.H. (1930) The Bacteriophage and its Clinical Application, Charles C. Thomas
  111. •D’Herelle, F. (1931) ‘Le phenomene de Twort et la bacteriophagie‘ Ann Inst Pasteur 47, 241
  112. •D’Herelle, F. (1931) ‘Le phenomene de Twort et la Bacteriophagie‘ Ann Inst Pasteur 46:618
  113. •D’Herelle (1931) ‘Le phenomene de Twort et la bacteriophagie‘ Ann Inst Pasteur 47:470-1
  114. •D’Herelle, F. (1933) Le Bactériophage et ses applications thérapeutiques, G. Doin et Cie
  115. •D’Herelle, F. (1935) Bacteriophag i fenomen vyzdorovleniya, Tbilisi National University
  116. •D’Herelle, F. (1938) Le Phénomène de la guérison dans les maladies infectieuses, Masson
  117. •D’Herelle, F. (1949) ‘Le bactériophage‘ Atomes 3:399-403
  118. •D’Herelle, F. (1949) ‘The bacteriophage‘ Science News (Penguin) 14:44-59
  119. •Da Costa Cruz, J. (1924) ‘La traitment des dysentéries bacillaires par le bactériophage‘ Compt Med Rend Soc Biol 91:845-6
  120. •Dabrowska, K. et al. (2005) ‘Bacteriophage penetration in vertebrates‘ J Appl Microbiol 98:7-13
  121. •Danelia, N. et al. (1998) ‘Bakteriophagen zur Therapie von multi-resistenten Bakterien’ Zeitschr Wundbeh 3: 16–17
  122. •Darsavelidze, M.A. et al. (2004) ‘Biological properties of bacteriophages, active to Yersinia enterocolitica‘ (Russian) Zh Mikrobiol Epidemiol Immunobiol 6:10-3
  123. •Das, P. (2001) ‘Bacteriophage therapy offers new hope for streptococcal infections‘ Lancet, 35:938
  124. •Davioud (1929) ‘Septico-pyohemie a staphylocoque doré par le bacteriophage intraveineux‘ Presse med 33:1413
  125. •Davison, W.C. (1922) ‘The bacteriolysis and therapy of bacillary dysentery  in children. Therapeutic application of bacteriolysants; d'Herelle's phenomenon‘ Am J Dis Child 23:531
  126. •Debattista, J. (2004) ‘Bacteriophage therapy: where East meets West‘ Expert Rev Anti Infect Ther 2:815-9
  127. •Delbrück, M. (1946) ‘Bacterial viruses or bacteriophages‘ Biol Rev 21:30-40
  128. •Delmastro, P. et al. (1997) ‘Immunogenicity of filamentous phage displaying peptide mimotopes after oral adminsitration‘ Vaccine 15:1276-1285
  129. •Dhayagude, R.G. and Banker D.D. ‘Treatment of typhoid fever with bacteriophage‘ Ind J med res 37:249
  130. •Dixon, B. (1984) ‘Attack of the phages‘ Science 84:66-69
  131. •Dixon, B. (1987) ‘Bacteriophage therapy‘ BMJ Clin Res Ed 294:1168
  132. •Dixon, B. (2004) ‘New dawn for phage therapy‘ Lancet Infect Dis 4:186Weld, Weld, R.J. et al. (2004) ‘Models of phage growth and their applicability to phage therapy‘ J Theor Biol 227:1-11
  133. •Djurkovic S. et al. (2005) ‘Synergistic killing of streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance‘ Antimicrob Agent Chemother 49:1225-1228
  134. •Dodd, C.E.R. et al. (2004) ‘Longitudinal Study of Campylobacter jejuni Bacteriophages and Their Hosts from Broiler Chickens‘ Appl Environ Microbiol 70:3877-83
  135. •Doermann, A.D. (1948) ‘Lysis and lysis inhibition with Escherichia coli bacteriophage‘ J Bacteriol 55:257-275
  136. •Doermann, A.D. (1952) ‘The Intracellular Growth of Bacteriophages. I. Liberation of intracellular bacteriophage T4 by premature lysis with another phage or with cyanide‘ J Gen Physiol 35:645-656
  137. •Dubos, R.J. et al. (1943). ‘The multiplication of bacteriophage in vivo and its protective effects against an experimental infection with Shigella dysenteriae‘ J Exp Med 78:161-168
  138. •Duckworth, D. (1976) ‘Who discovered bacteriophage?‘ Bact rev 40:793-802
  139. •Duerr, D.M. et al. (2004) ‘Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier‘ J Virol Methods 116:177-180